0001510964-17-000001.txt : 20170403 0001510964-17-000001.hdr.sgml : 20170403 20170331214512 ACCESSION NUMBER: 0001510964-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170403 DATE AS OF CHANGE: 20170331 EFFECTIVENESS DATE: 20170403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CV Sciences, Inc. CENTRAL INDEX KEY: 0001510964 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 800944970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-283870 FILM NUMBER: 17732127 BUSINESS ADDRESS: STREET 1: 2688 SOUTH RAINBOW AVENUE, SUITE B CITY: LAS VEGAS STATE: NV ZIP: 89146 BUSINESS PHONE: 866-290-2157 MAIL ADDRESS: STREET 1: 2688 SOUTH RAINBOW AVENUE, SUITE B CITY: LAS VEGAS STATE: NV ZIP: 89146 FORMER COMPANY: FORMER CONFORMED NAME: CannaVEST Corp. DATE OF NAME CHANGE: 20130205 FORMER COMPANY: FORMER CONFORMED NAME: Foreclosure Solutions, Inc. DATE OF NAME CHANGE: 20110124 D 1 primary_doc.xml X0707 D LIVE 0001510964 CV Sciences, Inc. 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 866.290.2157 DELAWARE CannaVEST Corp. Foreclosure Solutions, Inc. Corporation true Michael Mona, Jr. 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Executive Officer Director Michael Mona III 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Executive Officer Director JOSEPH DOWLING 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Executive Officer GARY SLIGAR 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Director LARRY RASKIN 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Director JAMES MCNULTY 2688 SOUTH RAINBOW BOULEVARD, SUITE B LAS VEGAS NV NEVADA 89146 Director Other Decline to Disclose 06b false 2017-03-01 false true true Secured Convertible Promissory Note; Common Stock issuable upon conversion thereof false 750000 770000 750000 20000 The purchase price for the Secured Convertible Promissory Note is $750,000, computed as follows: $770,000 original principal balance, less an "original issue discount" of $15,000, less a $5,000 reimbursement of Investor's legal fees. false 1 0 0 0 false CV Sciences, Inc. /s/ Michael Mona, Jr. Michael Mona, Jr. Chief Executive Officer and President 2017-03-31